BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 240 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 1.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $53,857,000 | -29.1% | 356,257 | -31.7% | 0.01% | -10.0% |
| Q2 2022 | $75,999,000 | +24.3% | 521,580 | +1.1% | 0.01% | +66.7% |
| Q1 2022 | $61,155,000 | -4.8% | 515,771 | +10.7% | 0.01% | 0.0% |
| Q4 2021 | $64,216,000 | +9.0% | 465,977 | +9.8% | 0.01% | 0.0% |
| Q3 2021 | $58,928,000 | +63.7% | 424,217 | +14.4% | 0.01% | +100.0% |
| Q2 2021 | $35,990,000 | +240.7% | 370,729 | +139.9% | 0.00% | +200.0% |
| Q1 2021 | $10,563,000 | -20.3% | 154,547 | -0.1% | 0.00% | 0.0% |
| Q4 2020 | $13,261,000 | +688.4% | 154,716 | +497.9% | 0.00% | – |
| Q3 2020 | $1,682,000 | -9.8% | 25,876 | +1.4% | 0.00% | – |
| Q2 2020 | $1,865,000 | +108.8% | 25,510 | -2.8% | 0.00% | – |
| Q1 2020 | $893,000 | -36.4% | 26,238 | +1.8% | 0.00% | – |
| Q4 2019 | $1,403,000 | +46.6% | 25,776 | +12.4% | 0.00% | – |
| Q3 2019 | $957,000 | +16.0% | 22,930 | +21.8% | 0.00% | – |
| Q2 2019 | $825,000 | -91.8% | 18,831 | -95.0% | 0.00% | -100.0% |
| Q4 2017 | $10,119,000 | -27.6% | 375,048 | +0.3% | 0.00% | 0.0% |
| Q3 2017 | $13,978,000 | +12.7% | 373,948 | -24.6% | 0.00% | 0.0% |
| Q2 2017 | $12,403,000 | – | 496,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |